Latest studies
- RecruitingPhase IV
Are RNA signatures (biomarkers) in the tissue which surrounds the joints (synovial tissue) from patients with rheumatoid arthritis predictive of response to drug treatments?
This UK clinical study tests whether examining a small sample of joint tissue can help doctors pick the best medicine for rheumatoid arthritis. Adults with active arthritis will have a minor joint biopsy and receive one of two standard biologic medicines to see if tissue tests improve treatment success.
Rheumatoid arthritisBelgium - CompletedPhase III
A study comparing talquetamab in combination with daratumumab or in combination with daratumumab and pomalidomide versus daratumumab in combination with pomalidomide and dexamethasone in participants with multiple myeloma that returns after treatment or is resistant to treatment
This study tests whether a new medicine called talquetamab, given alongside other cancer drugs, helps people with multiple myeloma that has returned or stopped responding to past treatments. Researchers want to see if these new combinations keep the cancer under control for longer than the current standard treatment.
Relapsed or refractory multiple myelomaBelgium - RecruitingPhase I/II
A trial looking at different treatments for neuroblastoma which has come back after initial therapy
The BEACON2 trial is testing new combinations of cancer medicines for children and young people whose neuroblastoma has returned or worsened after initial treatment. The goal is to find out which drug combinations are safest and work best to control the disease and improve future care.
Relapsed NeuroblastomaBelgium - CompletedPhase III
A randomized, open-label phase 3 study of amivantamab + FOLFIRI versus cetuximab/bevacizumab + FOLFIRI in participants with KRAS/NRAS and BRAF wildtype recurrent, unresectable or metastatic colorectal cancer who have received prior chemotherapy
This clinical trial is testing a new targeted drug, amivantamab, combined with chemotherapy for people with advanced bowel cancer. Researchers want to see if this combination works better at slowing cancer growth and helping people live longer than current standard targeted treatments after their first chemotherapy has stopped working.
Recurrent, unresectable or metastatic colorectal cancerBelgium - RecruitingPhase IV
The 3TR-PARTNER-RA study: Are RNA signatures (biomarkers) in the tissue which surrounds the joints (synovial tissue) from patients with early Rheumatoid Arthritis (symptoms <12 months) predictive of response to biologic drug treatments?
This UK clinical study investigates whether testing a tiny sample of joint tissue can help doctors choose the most effective treatment for early rheumatoid arthritis. Researchers want to see if specific biological markers can predict whether a modern medicine called abatacept works well for newly diagnosed patients.
Rheumatoid arthritisBelgium - RecruitingPhase I
A study of JNJ-95804306 for relapsed or refractory hematological malignancies
This early-stage clinical trial is testing a new medicine called JNJ-95804306 for adults with blood cancers that have returned or stopped responding to standard treatments. Doctors want to find safe doses and check how well the body handles the drug when given alone or with other cancer therapies.
Hematologic neoplasms, blood cancerBelgium - CompletedPhase II
Testing new medicine for adults with Cystic Fibrosis who do not have access to the currently available CFTR-modulating drugs due to genetic mutations
This clinical trial tests a new three-in-one medicine for adults with cystic fibrosis who have rare genetic mutations. These patients cannot access currently approved treatments. Researchers are checking whether this daily combination of capsules can safely improve lung health after promising results in laboratory tests using patient cell samples.
Treatment of Cystic Fibrosis (CF) in patients with CFTR mutations who are responders in the organoid assayBelgium - RecruitingPHASE2, PHASE3
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
This study looks at a new medicine called ponsegromab for advanced pancreatic cancer that has spread, especially when patients have lost a lot of weight and feel very tired. It aims to see if adding ponsegromab to standard chemotherapy helps more than chemotherapy alone.
CachexiaMetastatic Pancreatic Ductal AdenocarcinomaBelgium - RecruitingPHASE3
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
This study, called DLLEVATE, is looking at a new treatment, ZL-1310, for people with small cell lung cancer that has come back. It compares ZL-1310 to other standard treatments to see if it's safe and works well. You might be eligible if you're over 18 and have had previous treatments.
Small-cell Lung CancerBelgium - RecruitingPHASE3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
This study is testing a new medicine, enicepatide, for people who are overweight or have obesity but do not have type 2 diabetes. It aims to see if the medicine helps with weight loss and if it's safe compared to a dummy medicine.
Obesity or OverweightBelgium - RecruitingPhase II
Finding the best treatment for lung disease from infection with Mycobacterium abscessus
This clinical trial is testing different combinations of antibiotics to find the best way to treat lung infections caused by Mycobacterium abscessus. The goal is to discover which medicines work best to clear the bacteria while causing the fewest and least severe side effects for patients.
Mycobacterium abscessus pulmonary diseaseBelgium - RecruitingPHASE3
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
This study is testing a new medicine, plozasiran, for people with very high triglycerides who have had pancreatitis. It will check if the medicine is safe and helps reduce the risk of future pancreatitis attacks. Participants will get either the study medicine or a dummy medicine.
Severe HypertriglyceridemiaBelgium - RecruitingPHASE3
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
This study looks at a new drug, elritercept, for people with myelofibrosis and anaemia who are already taking ruxolitinib. It compares elritercept to a dummy drug (placebo) to see if it improves anaemia and other symptoms, and how safe it is.
MyelofibrosisAnemiaBelgium - Completed
Vitamin D and lifestyle Intervention for gestational diabetes mellitus (GDM) prevention
This study looks at ways to prevent gestational diabetes, which is high blood sugar during pregnancy. Researchers are testing whether vitamin D supplements, healthy eating advice, regular physical activity, or combinations of these can help pregnant women with a higher body mass index stay healthy throughout their pregnancy.
Gestational diabetesBelgium - CompletedPhase II
A Phase II study to understand the safety and effects of inhaled SNG001, the study medication, in patients who are mechanically ventilated due to a respiratory viral infection in the lungs
This study tests an inhaled medicine called SNG001 for people in intensive care with severe chest infections caused by viruses like flu or COVID-19. Researchers want to see if breathing in this natural virus-fighting protein helps patients recover faster and spend less time on a breathing machine.
Respiratory viral infectionsBelgium - Recruiting
Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
Researchers are testing a gentle sticky-tape test to detect melanoma, a serious skin cancer. Currently, doctors must cut away suspicious moles to test them. This study investigates whether simple skin tape can accurately collect cells and spot cancer markers, potentially saving many patients from having unnecessary minor surgery in the future.
MelanomaBelgium - RecruitingPHASE3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
This study looks at a new treatment called AAA617 for men with early-stage prostate cancer that has spread a little (oligometastatic). It compares AAA617 to careful watching, to see if it can stop the cancer from growing and help men live better for longer.
Oligometastatic Prostate Cancer (OMPC)Belgium - RecruitingPhase III
Phase 3, randomised, double-blind, placebo- controlled, 3-arm study to investigate the safety and efficacy of efimosfermin alfa in participants with biopsy-confirmed F2- or F3-stage metabolic dysfunction-associated steatohepatitis (MASH) (ZENITH-1)
This clinical trial is testing a new injection called efimosfermin alfa for people with metabolic dysfunction-associated steatohepatitis (MASH), an inflamed fatty liver condition. Researchers want to see if monthly injections over four years can safely reduce liver fat, ease inflammation, and improve liver scarring compared to a dummy treatment.
Medical condition: Metabolic Dysfunction-Associated Steatohepatitis (MASH) Medical condition in lay language: Metabolic Fatty Liver Inflamation Therapeutic areas: Diseases [C] - Nutritional and Metabolic Diseases [C18]Belgium - Completed
Evaluation of a dermocosmetic regimen for acne-prone skin in volunteers with mild, moderate or severe skin conditions
Acne is a common skin condition that affects confidence and well-being. This study tests whether a daily skincare routine using Eucerin products helps clear mild to severe spots. Researchers want to see how well these creams work over a year in people aged 12 to 50 across the UK and worldwide.
Subjects with acne-prone skin aged 12-50 years with Investigator's Global Assessment (IGA) grades 2-4, evaluating treatment of mild to severe acne vulgaris.Belgium - RecruitingPhase III
A study of JNJ-78934804 in participants with moderately to severely active Crohn's disease
This clinical trial is testing a new combination medicine, JNJ-78934804, for moderate to severe Crohn’s disease. It combines two drugs into one injection to target gut inflammation. Researchers want to see if this two-in-one approach works better than a single medicine for people whose previous treatments have stopped working.
Crohn’s diseaseBelgium - CompletedPhase I
A study to develop a computer model for measuring how a drug is distributed in the lungs
This study looks at how medicines from three standard inhalers travel inside the lungs. Researchers are studying healthy people and those with asthma or COPD. By taking scans of the lungs, they hope to build a computer simulation. This will help scientists design better, more effective inhalers in the future.
Chronic obstructive pulmonary disease (COPD), asthmaBelgium - Not yet recruiting
Phase 3a and 3b update of the gastric cancer module, EORTC QLQ-STO22
Researchers are updating a widely used questionnaire that measures how stomach cancer and modern treatments affect daily life and well-being. If you have stomach cancer, you can help by completing the draft survey and sharing your feedback during a single, one-off chat lasting up to an hour.
Gastric adenocarcinomaBelgium - Recruiting
New measurements of human sperm motility as a prediction of fertility
This study looks at whether smart computer software can track how sperm swim to predict fertility success. Researchers in Birmingham will analyse routine laboratory videos of sperm during normal fertility treatments. Taking part does not change your care or add appointments, but it could improve future fertility treatments for others.
Fertility; infertility; semen analysis; sperm testingBelgium - RecruitingTherapeutic exploratory (Phase II)
C1071003 - MAGNETISMM-3, An Open-Label, Multicenter, Non-Randomized Phase 2 Study of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One Proteasome Inhibitor, One Immunomodulatory Drug and One Anti-CD38 Antibody
This clinical trial is testing a new medicine called elranatamab for adults with multiple myeloma. It is designed for people whose cancer has returned or stopped responding after trying three standard types of treatment. The aim is to find out how well the drug works on its own.
Multiple myelomaBelgium - RecruitingHuman Pharmacology (Phase I)- Other
A clinical trial of MK-7228 in adults (MK-7228-002)
This early-stage clinical trial is testing a new study medicine called MK-7228 in adults. Researchers want to see how safe the drug is and how the human body processes it. The study aims to support future treatments for atherosclerosis, a condition where arteries become narrowed by fatty build-ups.
AtherosclerosisBelgium - RecruitingTherapeutic exploratory (Phase II)
A Phase 2 Study to Investigate the Safety and Efficacy of Petosemtamab in Adults with Non-Small Cell Lung Cancer in Combination with Pembrolizumab.
This clinical trial is testing a new drug called petosemtamab combined with an established immunotherapy called pembrolizumab (Keytruda). It aims to find out if this combination is safe and effective at shrinking tumours in adults diagnosed with non-small cell lung cancer.
Non Small Cell Lung CancerBelgium - AuthorisedPhase I and Phase II (Integrated)- First administration to humans
Phase 1-2, Open-Label, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION337 in Patients with Dravet Syndrome
This early clinical trial is testing an experimental medicine called ION337 for people with Dravet syndrome. Researchers want to find out if the drug is safe, how the body handles it, and whether it can help reduce the number of major seizures patients experience.
Dravet SyndromeBelgium - AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection
This clinical trial looks at whether a targeted medicine called taletrectinib can stop lung cancer from returning. It is for adults who have had surgery to completely remove non-small cell lung cancer with a specific gene change known as ROS1. Participants take either taletrectinib capsules or dummy capsules.
Non Small Cell Lung Cancer (NSCLC)Belgium - AuthorisedTherapeutic confirmatory (Phase III)
A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
This study tests an inhaled dry powder medicine called treprostinil palmitil for adults with high blood pressure in the lungs linked to lung scarring. The trial lasts up to two years to see if the medicine is safe and helps improve breathing, walking ability, and overall quality of life.
Pulmonary Hypertension Associated with Interstitial Lung DiseaseBelgium - AuthorisedTherapeutic use (Phase IV)
Oral versus Intravenous Tranexamic Acid for Blood Loss Prevention in Off-Pump Coronary Artery Bypass Surgery: A Randomised Non-Inferiority Trial (TRANSCAB Study)
This study compares two ways of giving a medicine called tranexamic acid to reduce bleeding during heart bypass surgery. Doctors want to see if taking it as a simple tablet works just as well as giving it through a drip into a vein, while keeping patients safe.
Coronary artery disease requiring off-pump coronary artery bypass surgery (OPCAB)Belgium - AuthorisedTherapeutic exploratory (Phase II)
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Surovatamig in Adults with Antibody-mediated Kidney Disease
This study tests a new medicine called surovatamig for adults with kidney disease caused by the immune system. Doctors want to see if it is safe and can lower protein leaking into the urine, which helps protect kidney function. Everyone in the trial receives the active study medicine.
Antibody-mediated Kidney DiseaseBelgium - AuthorisedTherapeutic confirmatory (Phase III)
Colchicine for the Reduction of Dependency and Vascular Events after an Acute Intracerebral Hemorrhage (CoVasc-ICH2)
This trial looks at whether an anti-inflammatory medicine called colchicine can help people recover after bleeding in the brain. Researchers want to find out if taking a daily tablet reduces the chances of future strokes, heart attacks, and long-term disability compared to taking a dummy tablet.
Major cardiovascular events (MACE), spontaneous intracerebral hemorrhageBelgium - AuthorisedHuman Pharmacology (Phase I)- First administration to humans
A First-in-Human Study of INCA035784 in Participants With Myeloproliferative Neoplasms
This early-stage clinical trial tests a new drug, INCA035784, in humans for the first time. It is for adults with myeloproliferative neoplasms (rare blood disorders where the body makes too many blood cells). Researchers want to find out if the medicine is safe and what dose works best.
Myeloproliferative NeoplasmsBelgium - AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Efficacy of Gildeuretinol Acetate (ALK-001) on the Progression of Stargardt Disease (STGD) - NORTHSTAR
This phase 3 study tests whether a new medicine called gildeuretinol acetate can slow down vision loss in adults with Stargardt disease. Participants take daily capsules containing either the trial drug or an inactive dummy pill (placebo) for two years, while eye doctors track their vision and retinal health.
Stargardt Disease (STGD1)Belgium - AuthorisedTherapeutic confirmatory (Phase III)
A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator’s Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
This study is testing a new targeted cancer drug called azenosertib. It is for women with advanced ovarian, fallopian tube, or peritoneal cancer that has returned after standard platinum chemotherapy. Researchers want to see if azenosertib works better than standard chemotherapy options at keeping the cancer under control.
High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerBelgium - AuthorisedTherapeutic exploratory (Phase II)
HOVON 168: Epcoritamab in Addition to R-Mini-CHOP Compared to R-Mini-CHOP in Elderly, Frail or Unfit Patients with Diffuse Large B-cell Lymphoma
This study looks at a new drug combination for older or frail adults with diffuse large B-cell lymphoma, a type of blood cancer. Researchers want to see if adding an antibody drug called epcoritamab to standard, gentler chemotherapy helps clear the cancer better and keeps people well for longer.
Diffuse large B-cell lymphoma (DLBCL)Belgium - AuthorisedTherapeutic exploratory (Phase II)
Randomized, Multicenter, Vehicle-Controlled, Double-Masked Study to Evaluate the Efficacy and Safety of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF]) in Adult Participants with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
This clinical trial is testing a new nasal spray called cenegermin for adults with NAION, an eye condition causing sudden sight loss. Researchers want to see if this treatment helps repair damaged nerve cells and improves vision on an eye chart over a period of 24 weeks.
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Belgium - AuthorisedPhase I and Phase II (Integrated)- First administration to humans
Phase 1/2, first-in-human, randomized, double-blind, reference-controlled study to evaluate the safety and immunogenicity of an extemporaneously mixed Combo Inactivated Influenza Vaccine (Green Cross [GC]-IIV; 15µg of each hemagglutinin [HA])/OVX836 (480µg), in comparison to GC-IIV (15µg of each HA) concomitantly administered with OVX836 (480µg), GC-IIV alone (15 µg each HA), OVX836 alone (480µg), and a licensed reference trivalent IIV (Vaxigrip®; 15µg of each HA), administered intramuscularly (IM) in healthy participants
This clinical trial is testing a new combination flu jab in healthy adults aged 18 and over. Researchers want to see if combining a standard seasonal flu vaccine with a new investigational vaccine is safe and helps the body produce a strong immune defence against influenza over six months.
Influenza diseaseBelgium - AuthorisedTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Participants with Sjogren’s Disease-Associated Sensorimotor or Sensory Polyneuropathy
This study tests a medicine called Vyvgart in adults with Sjögren's disease who have nerve damage in their hands, legs, or feet. Researchers want to see if regular injections under the skin can ease nerve symptoms, reduce fatigue, and be used safely compared with a dummy treatment.
Sjogren’s Disease-Associated Sensorimotor Polyneuropathy (SMPN) or Sensory Polyneuropathy (SPN)Belgium - AuthorisedTherapeutic exploratory (Phase II)
A Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long Term Safety and Tolerability of KT-621 in Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
This study looks at the long-term safety of a new medicine called KT-621 for adults with moderate to severe eosinophilic asthma. It is an extension study for people who already took part in an earlier KT-621 trial, checking how well the body tolerates the treatment over 52 weeks.
Uncontrolled Moderate to Severe Eosinophilic AsthmaBelgium - AuthorisedTherapeutic exploratory (Phase II)
Pilot study with Low-dose nivolumab in Advanced Neoplasms that are TMB-high
This early-stage study tests whether a lower dose of an immunotherapy drug called nivolumab can treat advanced cancers with many genetic changes, known as TMB-high tumours. Researchers want to see if this lower dose works well to shrink tumours while keeping side effects as low as possible.
TMB-high advanced neoplasmsBelgium - AuthorisedTherapeutic use (Phase IV)
Attachment Development and Learning in ADHD: The Role of Dopamine.
This clinical study investigates how standard ADHD medication influences children's relationships with their parents or carers. Researchers want to understand whether dopamine, a natural chemical messenger in the brain, helps young people with ADHD learn to build trust, seek emotional support, and respond to close family bonds.
Attention-Deficit/Hyperactivity Disorder (ADHD)Belgium - AuthorisedTherapeutic confirmatory (Phase III)
A phase III, randomised, double-blind, placebo-controlled, multicentre trial comparing efficacy and safety of trilaciclib versus placebo in participants with limited-stage small cell lung cancer
This study is testing a drug called trilaciclib for adults with limited-stage small cell lung cancer. Chemotherapy can damage bone marrow and lower white blood cells, raising infection risks. Researchers want to see if trilaciclib protects healthy blood cells and reduces side effects during standard cancer treatment.
Limited-stage small cell lung cancer (LS-SCLC)Belgium - AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination with the Modified Gemcitabine and nab-Paclitaxel Regimen Versus the Standard Gemcitabine and nab-Paclitaxel Regimen for the Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma Cancer (MAPKeeper 301)
This clinical trial is testing a new targeted medicine called atebimetinib for advanced pancreatic cancer. Doctors want to see if adding this drug to standard chemotherapy helps people live longer and improves their quality of life compared to standard chemotherapy alone.
Metastatic Pancreatic Ductal AdenocarcinomaBelgium - AuthorisedTherapeutic confirmatory (Phase III)
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)
This study is checking the long-term health of people who took part in an earlier trial for choroidal melanoma, a rare eye cancer. Researchers want to see how well a treatment called bel-sar protects vision and stops the tumour from growing or returning over several years.
Choroidal MelanomaBelgium - AuthorisedTherapeutic exploratory (Phase II)
A Multicenter, Open-Label, Phase II Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age with Systemic Lupus Erythematosus.
This study looks at a medicine called anifrolumab (Saphnelo) in children and young people aged 5 to 17 with lupus. Researchers want to find out how the body handles the medicine given as an injection under the skin, and to check that it is safe for younger patients.
Systemic Lupus ErythematosusBelgium - AuthorisedTherapeutic confirmatory (Phase III)
A randomized, open-label, multicenter, Phase 3 study to investigate mocertatug rezetecan compared with chemotherapy in participants with endometrial cancer after platinum-based chemotherapy and immunotherapy
This Phase 3 clinical trial tests a new drug called mocertatug rezetecan for womb (endometrial) cancer. Researchers want to see if it works better and is safer than standard chemotherapy for people whose cancer has returned or worsened after earlier treatments like platinum chemotherapy and immunotherapy.
Neoplasms, EndometrialBelgium - AuthorisedTherapeutic exploratory (Phase II)
A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Trial to Assess the Efficacy and Safety of Ontunisertib in Patients with Fibrostenosing Crohn’s Disease
This study tests a new medicine called ontunisertib for people with Crohn's disease who have narrowed sections in their bowel. Researchers want to find out if this daily capsule can reduce tough scar tissue, help widen the bowel, and improve symptoms compared to a dummy pill over one year.
Fibrostenosing Crohn’s DiseaseBelgium - AuthorisedTherapeutic exploratory (Phase II)
OASIS-ImmunoPET_Antibody-based PET imaging and treatment response in breast cancer treated with an antibody-drug conjugate according to current standard indications.
This study looks at a new type of body scan called an ImmunoPET scan for people with breast cancer. It tests whether using a special tracer can show how well a standard targeted medicine (T-DXd) is working, and if it can detect cancer spread earlier than usual scans.
Belgium - AuthorisedTherapeutic exploratory (Phase II)
Use of the Checkpoint inhibitor DOstarlimab in the endOmetrial cancer fertility-Sparing trEatment: CHOOSE study.
The CHOOSE study is looking at a new medicine called dostarlimab for women with newly diagnosed womb cancer. The goal is to see if this treatment can clear the cancer without needing surgery to remove the womb, helping patients keep their ability to have children in the future.
Newly diagnosed endometrial carcinomas of the MMR-deficient molecular subtypeBelgium